Atrogin1-induced loss of aquaporin 4 in myocytes leads to skeletal muscle atrophy.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 08 2020
Historique:
received: 17 02 2020
accepted: 10 08 2020
entrez: 27 8 2020
pubmed: 28 8 2020
medline: 12 1 2021
Statut: epublish

Résumé

The water channel aquaporin 4 (AQP4) regulates the flux of water across the cell membrane, maintaining cellular homeostasis. Since AQP4 is enriched in the sarcolemma of skeletal muscle, a functional defect in AQP4 may cause skeletal muscle dysfunction. To investigate a novel mechanism underlying skeletal muscle atrophy, we examined AQP4 expression and its regulation in muscle using the rotator cuff tear (RCT) model. Human and mouse AQP4 expression was significantly decreased in atrophied muscle resulting from RCT. The size and the number of myotubes were reduced following AQP4 knockdown. Atrogin 1-mediated ubiquitination of AQP4 was verified with an ubiquitination assay after immunoprecipitation of AQP4 with an anti-AQP4 antibody. In this study, we identified high mobility group box 1 (HMGB1) as a potent upstream regulator of atrogin 1 expression. Atrogin 1 expression was increased by recombinant mouse HMGB1 protein, and the HMGB1-induced atrogin 1 expression was mediated via NF-κB signaling. Our study suggests that loss of AQP4 appears to be involved in myocyte shrinkage after RCT, and its degradation is mediated by atrogin 1-dependent ubiquitination. HMGB1, in its function as a signaling molecule upstream of the ubiquitin ligase atrogin 1, was found to be a novel regulator of muscle atrophy.

Identifiants

pubmed: 32843684
doi: 10.1038/s41598-020-71167-8
pii: 10.1038/s41598-020-71167-8
pmc: PMC7447774
doi:

Substances chimiques

Aquaporin 4 0
HMGB1 Protein 0
Muscle Proteins 0
NF-kappa B 0
Tripartite Motif Proteins 0
Ubiquitin 0
Fbxo32 protein, mouse EC 2.3.2.27
SKP Cullin F-Box Protein Ligases EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14189

Références

Preston, G. M., Carroll, T. P., Guggino, W. B. & Agre, P. Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science 256, 385–387 (1992).
doi: 10.1126/science.256.5055.385
Hasegawa, H., Ma, T., Skach, W., Matthay, M. A. & Verkman, A. S. Molecular cloning of a mercurial-insensitive water channel expressed in selected water-transporting tissues. J. Biol. Chem. 269, 5497–5500 (1994).
pubmed: 7509789
Brown, D. The discovery of water channels (aquaporins). Ann. Nutr. Metab. 70(Suppl 1), 37–42. https://doi.org/10.1159/000463061 (2017).
doi: 10.1159/000463061 pubmed: 28614812
Frigeri, A., Nicchia, G. P., Verbavatz, J. M., Valenti, G. & Svelto, M. Expression of aquaporin-4 in fast-twitch fibers of mammalian skeletal muscle. J. Clin. Investig. 102, 695–703. https://doi.org/10.1172/jci2545 (1998).
doi: 10.1172/jci2545 pubmed: 9710437
Liu, J. W. et al. Immunocytochemical studies of aquaporin 4 in the skeletal muscle of mdx mouse. J. Neurol. Sci. 164, 24–28 (1999).
doi: 10.1016/S0022-510X(99)00051-9
Adams, M. E., Mueller, H. A. & Froehner, S. C. In vivo requirement of the α-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J. Cell Biol. 155, 113–122. https://doi.org/10.1083/jcb.200106158 (2001).
doi: 10.1083/jcb.200106158 pubmed: 11571312 pmcid: 2150783
Neely, J. D. et al. Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein. Proc. Natl. Acad. Sci. U.S.A. 98, 14108–14113. https://doi.org/10.1073/pnas.241508198 (2001).
doi: 10.1073/pnas.241508198 pubmed: 11717465 pmcid: 61176
Basco, D. et al. AQP4-dependent water transport plays a functional role in exercise-induced skeletal muscle adaptations. PLoS ONE 8, e58712. https://doi.org/10.1371/journal.pone.0058712 (2013).
doi: 10.1371/journal.pone.0058712 pubmed: 23520529 pmcid: 3592820
Frigeri, A. et al. Muscle loading modulates aquaporin-4 expression in skeletal muscle. FASEB J. 15, 1282–1284 (2001).
doi: 10.1096/fj.00-0525fje
Fanzani, A., Conraads, V. M., Penna, F. & Martinet, W. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J. Cachexia Sarcopenia Muscle 3, 163–179. https://doi.org/10.1007/s13539-012-0074-6 (2012).
doi: 10.1007/s13539-012-0074-6 pubmed: 22673968 pmcid: 3424188
Kalyani, R. R., Corriere, M. & Ferrucci, L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2, 819–829. https://doi.org/10.1016/s2213-8587(14)70034-8 (2014).
doi: 10.1016/s2213-8587(14)70034-8 pubmed: 24731660 pmcid: 4156923
Wing, S. S. & Goldberg, A. L. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol. 264, E668–E676. https://doi.org/10.1152/ajpendo.1993.264.4.E668 (1993).
doi: 10.1152/ajpendo.1993.264.4.E668 pubmed: 7682781
Bonaldo, P. & Sandri, M. Cellular and molecular mechanisms of muscle atrophy. Dis. Model Mech. 6, 25–39. https://doi.org/10.1242/dmm.010389 (2013).
doi: 10.1242/dmm.010389 pubmed: 23268536 pmcid: 3529336
Bodine, S. C. & Baehr, L. M. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am. J. Physiol. Endocrinol. Metab. 307, E469-484. https://doi.org/10.1152/ajpendo.00204.2014 (2014).
doi: 10.1152/ajpendo.00204.2014 pubmed: 25096180 pmcid: 4166716
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A. & Goldberg, A. L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. U.S.A. 98, 14440–14445. https://doi.org/10.1073/pnas.251541198 (2001).
doi: 10.1073/pnas.251541198 pubmed: 11717410 pmcid: 64700
Glass, D. J. Molecular mechanisms modulating muscle mass. Trends Mol. Med. 9, 344–350 (2003).
doi: 10.1016/S1471-4914(03)00138-2
Zhang, G., Jin, B. & Li, Y. P. C/EBPbeta mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. EMBO J. 30, 4323–4335. https://doi.org/10.1038/emboj.2011.292 (2011).
doi: 10.1038/emboj.2011.292 pubmed: 21847090 pmcid: 3199382
Clarke, B. A. et al. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab. 6, 376–385. https://doi.org/10.1016/j.cmet.2007.09.009 (2007).
doi: 10.1016/j.cmet.2007.09.009 pubmed: 17983583
Rubel, C. E. et al. Diggin’ on u(biquitin): a novel method for the identification of physiological E3 ubiquitin ligase substrates. Cell Biochem. Biophys. 67, 127–138. https://doi.org/10.1007/s12013-013-9624-6 (2013).
doi: 10.1007/s12013-013-9624-6 pubmed: 23695782 pmcid: 3758785
Pillon, N. J. & Krook, A. Innate immune receptors in skeletal muscle metabolism. Exp. Cell Res. 360, 47–54. https://doi.org/10.1016/j.yexcr.2017.02.035 (2017).
doi: 10.1016/j.yexcr.2017.02.035 pubmed: 28232117
Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191–195. https://doi.org/10.1038/nature00858 (2002).
doi: 10.1038/nature00858 pubmed: 12110890 pmcid: 12110890
Yang, H., Wang, H., Chavan, S. S. & Andersson, U. High mobility group box protein 1 (HMGB1): the prototypical endogenous danger molecule. Mol. Med. 21(Suppl 1), S6-s12. https://doi.org/10.2119/molmed.2015.00087 (2015).
doi: 10.2119/molmed.2015.00087 pubmed: 26605648 pmcid: 4661054
Goutallier, D., Postel, J. M., Bernageau, J., Lavau, L. & Voisin, M. C. Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin. Orthop. Relat. Res. 304, 78–83 (1994).
Kuzel, B. R., Grindel, S., Papandrea, R. & Ziegler, D. Fatty infiltration and rotator cuff atrophy. J. Am. Acad. Orthop. Surg. 21, 613–623. https://doi.org/10.5435/JAAOS-21-10-613 (2013).
doi: 10.5435/JAAOS-21-10-613 pubmed: 24084435
Perry, S. M., Getz, C. L. & Soslowsky, L. J. Alterations in function after rotator cuff tears in an animal model. J. Shoulder Elbow Surg. 18, 296–304. https://doi.org/10.1016/j.jse.2008.10.008 (2009).
doi: 10.1016/j.jse.2008.10.008 pubmed: 19218053 pmcid: 2669656
Edelstein, L., Thomas, S. J. & Soslowsky, L. J. Rotator cuff tears: what have we learned from animal models?. J. Musculoskelet. Neuronal. Interact. 11, 150–162 (2011).
pubmed: 21625052
Lee, Y. S., Kim, J. Y., Oh, K. S. & Chung, S. W. Fatty acid-binding protein 4 regulates fatty infiltration after rotator cuff tear by hypoxia-inducible factor 1 in mice. J. Cachexia Sarcopenia Muscle 8, 839–850. https://doi.org/10.1002/jcsm.12203 (2017).
doi: 10.1002/jcsm.12203 pubmed: 28382782 pmcid: 5659062
McCarthy, C. G. & Webb, R. C. The toll of the gridiron: damage-associated molecular patterns and hypertension in American football. FASEB J. 30, 34–40. https://doi.org/10.1096/fj.15-279588 (2016).
doi: 10.1096/fj.15-279588 pubmed: 26316270
Kong, H. et al. AQP4 knockout impairs proliferation, migration and neuronal differentiation of adult neural stem cells. J. Cell Sci. 121, 4029–4036. https://doi.org/10.1242/jcs.035758 (2008).
doi: 10.1242/jcs.035758 pubmed: 19033383
Basco, D. et al. Absence of aquaporin-4 in skeletal muscle alters proteins involved in bioenergetic pathways and calcium handling. PLoS ONE 6, e19225. https://doi.org/10.1371/journal.pone.0019225 (2011).
doi: 10.1371/journal.pone.0019225 pubmed: 21552523 pmcid: 3084271
Ishido, M. & Nakamura, T. Marked decrease of aquaporin-4 protein is independent of the changes in alpha1-syntrophin and TRPV4 levels in response to denervation-induced muscle atrophy in vivo. J. Muscle Res. Cell Motil. 38, 175–181. https://doi.org/10.1007/s10974-017-9471-y (2017).
doi: 10.1007/s10974-017-9471-y pubmed: 28488242
Crosbie, R. H. et al. Characterization of aquaporin-4 in muscle and muscular dystrophy. FASEB J. 16, 943–949. https://doi.org/10.1096/fj.01-0327com (2002).
doi: 10.1096/fj.01-0327com pubmed: 12087055
Ishido, M. & Nakamura, T. Aquaporin-4 protein is stably maintained in the hypertrophied muscles by functional overload. Acta Histochem. Cytochem. 49, 89–95. https://doi.org/10.1267/ahc.16005 (2016).
doi: 10.1267/ahc.16005 pubmed: 27462134 pmcid: 4939316
Glass, D. J. Signaling pathways perturbing muscle mass. Curr. Opin. Clin. Nutr. Metab. Care 13, 225–229 (2010).
doi: 10.1097/MCO.0b013e32833862df
Bodine, S. C. et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704–1708. https://doi.org/10.1126/science.1065874 (2001).
doi: 10.1126/science.1065874 pubmed: 11679633
Roche, J. V. & Tornroth-Horsefield, S. Aquaporin protein–protein interactions. Int. J. Mol. Sci. https://doi.org/10.3390/ijms18112255 (2017).
doi: 10.3390/ijms18112255 pubmed: 29295477 pmcid: 5795988
Dibas, A., Yang, M. H., He, S., Bobich, J. & Yorio, T. Changes in ocular aquaporin-4 (AQP4) expression following retinal injury. Mol. Vis. 14, 1770–1783 (2008).
pubmed: 18836575 pmcid: 2559817
Zhang, L. et al. Stat3 activation links a C/EBPdelta to myostatin pathway to stimulate loss of muscle mass. Cell Metab. 18, 368–379. https://doi.org/10.1016/j.cmet.2013.07.012 (2013).
doi: 10.1016/j.cmet.2013.07.012 pubmed: 24011072 pmcid: 3794464
Ding, H. et al. Activin A induces skeletal muscle catabolism via p38beta mitogen-activated protein kinase. J. Cachexia Sarcopenia Muscle 8, 202–212. https://doi.org/10.1002/jcsm.12145 (2017).
doi: 10.1002/jcsm.12145 pubmed: 27897407
Kim, H. E., Rhee, J., Park, S., Yang, J. & Chun, J. S. Upregulation of Atrogin-1/FBXO32 is not necessary for cartilage destruction in mouse models of osteoarthritis. Osteoarthr. Cartil. 25, 397–400. https://doi.org/10.1016/j.joca.2016.07.008 (2017).
doi: 10.1016/j.joca.2016.07.008 pubmed: 27480933

Auteurs

Seok Won Chung (SW)

Department of Orthopedic Surgery, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea.

Ja-Yeon Kim (JY)

Department of Orthopedic Surgery, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea.

Jong Pil Yoon (JP)

Department of Orthopedic Surgery, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

Dong Won Suh (DW)

Joint Center, Barunsesang Hospital, #75-5, Yatap-ro, Seongnam-si, Gyeonggi-do, 13497, Republic of Korea.

Woo Jin Yeo (WJ)

Joint Center, Barunsesang Hospital, #75-5, Yatap-ro, Seongnam-si, Gyeonggi-do, 13497, Republic of Korea.

Yong-Soo Lee (YS)

Department of Orthopedic Surgery, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea. hrcyslee@yahoo.co.kr.
Joint Center, Barunsesang Hospital, #75-5, Yatap-ro, Seongnam-si, Gyeonggi-do, 13497, Republic of Korea. hrcyslee@yahoo.co.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH